IA
FENC icon

IFP Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

IFP Advisors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989 Buy
92
+91
+9,100% +$743 ﹤0.01% 4497
2026
Q1 		$6 Buy
+1
New +$8 ﹤0.01% 4986
2025
Q2 		– Sell
-7
Closed -$43 – 4952
2025
Q1 		$43 Hold
7
– – ﹤0.01% 4048
2024
Q4 		$44 Buy
+7
New +$36 ﹤0.01% 4286

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

IFP Advisors's FENC Position: Q2 2026 in Review

IFP Advisors increased its Fennec Pharmaceuticals (FENC) stake by 9,100% in Q2 2026, buying an estimated $743 and bringing the position to 92 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #4497.

IFP Advisors first reported a position in FENC in Q4 2024 and has held it in 4 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • IFP Advisors held 92 shares of Fennec Pharmaceuticals worth $989 as of Q2 2026.
  • IFP Advisors bought 91 Fennec Pharmaceuticals shares in Q2 2026, an estimated $743.
  • Fennec Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4497 holding.
  • IFP Advisors first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.